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No end-PCI icECG
ST-segment change
End-PCI icECG ST-
segment change p
TLR 4.3% (1/23) 11.4% (5/44) .046
MACE 8.7% (2/23) 19% (8/44) .042
Multivariate, proportional hazards Cox multiple regression model
Independent predictors for MACEs and 9-12 months
predictor HR p
MB residual ST-
elevation on
icECG
HR  1.469; CI 1.035-2.086 .032
CK-MB elevation
3xN
HR  2.4; CI 1.139-5.057 .021
Conclusions: The intracoronary ECG is a highly sensitive and specific method for
differentiation of ischemia region, prediction of periprocedural myonecrosis and future
adverse cardiac events.
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Background: Final kissing balloon dilatation (FKBD) is a recommended final step in case
of treatment of bifurcation lesions by two stents approaches. Furthermore, dilatation of the side
branch (SB) may be necessary following main vessel (MV) stenting. Occasionally, recrossing
the stent struts with a balloon is hampered because the tip hits a stent strut.
Methods: The Glider (TriReme Medical, Pleasanton, CA; Figure) is a dedicated balloon
designed for crossing through struts of deployed stents toward a SB. From October 2010 to
January 2012.
Results: FKBD was attempted in 236 consecutive bifurcation lesions treated in our
Institution. FKBD was successfully performed by conventional balloon catheters in 221
(93.5%) lesions (Conventional group). In the remaining 15 (6.5%) lesions, where a conven-
tional balloon failed to cross the stent strut, the Glider balloon was attempted (Glider group)
(Table). The angle beta (between the axis of the MV after the branch point and the SB axis at
the point of divergence) was wider in the Glider group (8317° versus 6527°; p 0.032).
A trend toward an higher rate of the true bifurcation lesions was observed in the Glider group
(93% versus 70.5%; p  0.07). The Glider balloon successfully crossed through MV stent
struts toward a SB in 12 patients (80%), whereas failed in the remaining 3 patients.
Conventional group Glider group
P(n  221) (n  15)
Vessel treated 0.25
Distal LM 35 (16%) 3 (20%)
LAD-diagonal 132 (59.5%) 8 (53.5%)
LCx-MO 40 (18%) 3 (20%)
PD-PL 14 (6.5%) 1 (6.5%)
Lesion site 0.47
Ostial - -
Proximal 101(45.5%) 7 (47%)
Middle 65 (29.5%) 4 (26.5%)
Distal 55 (25%) 4 (26.5%)
Reference vessel diameter, mm
Main vessel 3.11  0.51 3.21  0.44 0.59
Side branch 2.10  0.44 2.15  0,45 0.55
Lesion Length, mm
Main vessel 19  8 23  11 0.43
Side branch 64 73 0.88
True bifurcation lesion 156 (70.5%) 14 (93%) 0.07
Bifurcation angle (°)
alpha 153104 11529 0.22
beta 6527 83174 0.032
Diameter stenosis, %
Main vessel 839 8312 0.96
Side branch 5310 5512 0.85
Conclusions: The Glider balloon represents an unique bail-out device which offers an
effective rescue strategy for recrossing stent struts during complex bifurcation stenting.
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Background: Peri-procedural myocardial infarction (PMI, ESC/ACC type 4a) is
diagnosed on the basis of elevation of cardiac enzymesmore than three times the 99th
centile upper reference limit. Recent guidelines recommend the use of troponin instead of
creatine kinase (CK) to diagnose PMI, but this assay increases diagnostic sensitivity,
while the clinical significance of small increases in troponin remains undetermined. We
examined the effects of using the new definition on the incidence of a composite endpoint
(previously defined by CK) in acontemporary clinical randomized trial - the BBC ONE
bifurcation coronary stenting trial.
Methods: The BBC ONE trial randomly allocated 500 patients with coronary bifurcation
lesions to either a simple or complex stenting strategy. The composite primary endpoint
(CPEP) included death, MI (PMI	 subsequent MI) and target vessel failure, at 9 months.
Results: In BBC ONE the CPEP occurred in 8% vs15.2% in the simple and complex
groups respectively(HR 2.02 (1.17-3.47), p0.009). This difference was largely driven by
PMI, which occurred in 9 (3.6%) vs28 (11.2%) of patients (HR 3.24, (1.53-6.86),
p0.001).Using troponin, PMI would have occurred in 71 (28.4%) vs 114 (45.6%)
patients respectively (HR 1.61, (1.27-2.05), p0.001), and the CPEP in 32% vs 48% of
patients (HR 1.50, (1.2-1.87), p0.001). Use of troponin increased myocardial infarction
detection fivefold, from 7.4% to 37.0% overall.
Conclusions: Use of troponin would have led to a fivefold increase in diagnosis of
periprocedural myocardial infarction in the BBC ONE trial. Incorporation of PMI into a
composite endpoint may no longer be justified in many interventional trials.
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Background: The Tryton Side-Branch Stent (Tryton) (Tryton Medical) was designed to
treat complex bifurcation lesions (BL). We evaluated all treated patients with a clinical
and angiographic follow-up at 9 mos.
Methods: Tryton is a balloon-expandable cobalt-chromium bare-metal stent with a distal
zone that scaffolds the side branch (SB), a transition zone designed to accomodate any
ostial anatomy and a proximal zone designed to accomodate a standard stent. Tryton is
deployed with the transition zone at the SB origin with the distal end in the SB and
proximal zone into the main vessel (MV). Appropriately sized Xience Prime (Abbott
Vascular) stents were positioned in the MV with the proximal portion covering the Tryton
and the distal portion extending beyond the SB ostium into the distal MV.
Results: We enrolled one hundred-twenty-three consecutive patients (83% male, mean
age 64.69.6 years) with 125 BL (79 LAD-diagonal, 26 LCx-obtuse marginal, 8
RCA-posterior descending and 12 LM-LAD) and Medina classification showing 1.1.1 in
107, 1.1.0 in 12, 0.1.1 in 8. Lesion angle was  30° in 26,  30° and  45° in 75 and
45° in 24. Additional SB stenting, distal to the Tryton stent, was performed in
48(39%)cases to fully cover the lesion. Final kissing balloon was performed in all cases.
Procedural success was 100%. Postprocedural NSTEMI were observed in 17 (13.8%;
CK-MB3 ULN) pts. No definite stent thrombosis, rePCI, CABG occurred. One cardiac
unwitnessed death occurred 7 days after PCI in a previously large anterior STEMI pt.
Clinical and angiographic follow-up data, currently available in 113 (91%) patients are
shown in the Table.
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